Lian B - Search Results

1

Frequent Genetic Aberrations in the CDK4 Pathway in Acral Melanoma Indicate the Potential for CDK4/6 Inhibitors in Targeted Therapy.

Kong Y, Sheng X, Wu X, Yan J, Ma M, Yu J, Si L, Chi Z, Cui C, Dai J, Li Y, Yu H, Xu T, Tang H, Tang B, Mao L, Lian B, Wang X, Yan X, Li S, Guo J. Kong Y, et al. Among authors: lian b. Clin Cancer Res. 2017 Nov 15;23(22):6946-6957. doi: 10.1158/1078-0432.CCR-17-0070. Epub 2017 Aug 22. Clin Cancer Res. 2017. PMID: 28830923

2

Phase II randomized trial comparing high-dose IFN-α2b with temozolomide plus cisplatin as systemic adjuvant therapy for resected mucosal melanoma.

Lian B, Si L, Cui C, Chi Z, Sheng X, Mao L, Li S, Kong Y, Tang B, Guo J. Lian B, et al. Clin Cancer Res. 2013 Aug 15;19(16):4488-98. doi: 10.1158/1078-0432.CCR-13-0739. Epub 2013 Jul 5. Clin Cancer Res. 2013. PMID: 23833309 Clinical Trial.

3

Large-scale analysis of PDGFRA mutations in melanomas and evaluation of their sensitivity to tyrosine kinase inhibitors imatinib and crenolanib.

Dai J, Kong Y, Si L, Chi Z, Cui C, Sheng X, Mao L, Li S, Lian B, Yang R, Liu S, Xu X, Guo J. Dai J, et al. Among authors: lian b. Clin Cancer Res. 2013 Dec 15;19(24):6935-42. doi: 10.1158/1078-0432.CCR-13-1266. Epub 2013 Oct 16. Clin Cancer Res. 2013. PMID: 24132921

4

GNAQ and GNA11 mutations occur in 9.5% of mucosal melanoma and are associated with poor prognosis.

Sheng X, Kong Y, Li Y, Zhang Q, Si L, Cui C, Chi Z, Tang B, Mao L, Lian B, Wang X, Yan X, Li S, Dai J, Guo J. Sheng X, et al. Among authors: lian b. Eur J Cancer. 2016 Sep;65:156-63. doi: 10.1016/j.ejca.2016.06.019. Epub 2016 Aug 4. Eur J Cancer. 2016. PMID: 27498141

5

MAPK Pathway and TERT Promoter Gene Mutation Pattern and Its Prognostic Value in Melanoma Patients: A Retrospective Study of 2,793 Cases.

Bai X, Kong Y, Chi Z, Sheng X, Cui C, Wang X, Mao L, Tang B, Li S, Lian B, Yan X, Zhou L, Dai J, Guo J, Si L. Bai X, et al. Among authors: lian b. Clin Cancer Res. 2017 Oct 15;23(20):6120-6127. doi: 10.1158/1078-0432.CCR-17-0980. Epub 2017 Jul 18. Clin Cancer Res. 2017. PMID: 28720667

6

Identification of coexistence of BRAF V600E mutation and EZH2 gain specifically in melanoma as a promising target for combination therapy.

Yu H, Ma M, Yan J, Xu L, Yu J, Dai J, Xu T, Tang H, Wu X, Li S, Lian B, Mao L, Chi Z, Cui C, Guo J, Kong Y. Yu H, et al. Among authors: lian b. J Transl Med. 2017 Dec 4;15(1):243. doi: 10.1186/s12967-017-1344-z. J Transl Med. 2017. PMID: 29202777 Free PMC article.

7

Efficacy Evaluation of Imatinib for the Treatment of Melanoma: Evidence From a Retrospective Study.

Wei X, Mao L, Chi Z, Sheng X, Cui C, Kong Y, Dai J, Wang X, Li S, Tang B, Lian B, Yan X, Bai X, Zhou L, Guo J, Si L. Wei X, et al. Among authors: lian b. Oncol Res. 2019 Mar 29;27(4):495-501. doi: 10.3727/096504018X15331163433914. Epub 2018 Aug 3. Oncol Res. 2019. PMID: 30075827 Free PMC article.

8

Palbociclib for treatment of metastatic melanoma with copy number variations of CDK4 pathway: case report.

Tang B, Sheng X, Kong Y, Chi Z, Si L, Cui C, Yan X, Mao L, Lian B, Li S, Wang X, Dai J, Bai X, Zhou L, Guo J. Tang B, et al. Among authors: lian b. Chin Clin Oncol. 2018 Dec;7(6):62. doi: 10.21037/cco.2018.06.08. Epub 2018 Jul 12. Chin Clin Oncol. 2018. PMID: 30180747 Free article.

9

Primary malignant melanoma of the esophagus: A retrospective analysis of clinical features, management, and survival of 76 patients.

Wang X, Kong Y, Chi Z, Sheng X, Cui C, Mao L, Lian B, Tang B, Yan X, Si L, Guo J. Wang X, et al. Among authors: lian b. Thorac Cancer. 2019 Apr;10(4):950-956. doi: 10.1111/1759-7714.13034. Epub 2019 Mar 12. Thorac Cancer. 2019. PMID: 30864295 Free PMC article.

10

Genetic Aberrations in the CDK4 Pathway Are Associated with Innate Resistance to PD-1 Blockade in Chinese Patients with Non-Cutaneous Melanoma.

Yu J, Yan J, Guo Q, Chi Z, Tang B, Zheng B, Yu J, Yin T, Cheng Z, Wu X, Yu H, Dai J, Sheng X, Si L, Cui C, Bai X, Mao L, Lian B, Wang X, Yan X, Li S, Zhou L, Flaherty KT, Guo J, Kong Y. Yu J, et al. Among authors: lian b. Clin Cancer Res. 2019 Nov 1;25(21):6511-6523. doi: 10.1158/1078-0432.CCR-19-0475. Epub 2019 Aug 2. Clin Cancer Res. 2019. PMID: 31375512

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

582 results

Search Page

Filters